Inhibiting CTGF with antisense oligonucleotides or gene silencing was beneficial for experimental renal damage models, such as UUO mouse models, DN, and uninephrectomized TGF-β transgenic mice17,39–41. The gene discussed is CCN2; the disease is liver dysplastic nodule.